Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × tislelizumab × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 12 Solid Tumor 5 Advanced Solid Tumors 5 Solid Tumors 2 Sarcoma 2 Advanced Solid Tumour 2 Uterine Cervical Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Metastatic Solid Tumors 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Malignant Solid Tumors 1 MSI-H/dMMR Solid Tumors 1 MSI-H Colorectal Cancer 1 Locally Advanced or Metastatic Solid Tumors 1 Locally Advanced and Metastatic Solid Tumors 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anus Neoplasms 1 Advanced or Recurrent Solid Tumors 1 Advanced HCC 1

Interventions

pembrolizumab 6 Radiotherapy 3 Proton Therapy 3 Interleukin-2 3 Cyclophosphamide 3 spartalizumab 2 fludarabine 2 Paclitaxel 2 Ipilimumab 2 Immune Checkpoint Inhibitors 2 Cetuximab 2 Carboplatin 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 sotorasib 1 peposertib 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 niraparib 1 neotil 1 necitumumab 1 leronlimab 1 lenvatinib 1 atezolizumab 1 abemaciclib 1 Yoga 1 Watchful Waiting 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06032845 2025-02-27

CASTLE-11

Fudan University

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡